Bengaluru, NFAPost: AEROBIOVAC Canada is now exclusively distributing nationally the only Air Decontamination System (ADS) proven to KILL the SARS-CoV-2 (COVID-19) virus. The Patented AEROBIOTIX UVC Light technology has been clinically tested on live SARS-CoV-2 (COVID-19) aerosols and scientifically proven to KILL 100% of airborne viruses including SARS-CoV-2 (COVID-19) on a single pass through the Air Decontamination System (ADS). The Study details are given HERE.
“The hardest place to kill a pathogen is inside the human body. If we can eliminate the danger in the air before it gets a chance to enter the patient, the human and economic benefits are huge,” states David Kirschman, M.D., founder of Aerobiotix, Inc.
“Real-time treatment and monitoring of air quality provides a new tool for infection prevention to ensure the most hygienic care environments are achieved in their facilities,” states Dr. Kirschman.
“The medical-grade air disinfection systems ELIMINATE all airborne contaminants while current HVAC systems simply filter the air,” says Andy Kostopoulos, President of Extreme Air Systems.
“Although many HEPA filtration systems are making similar claims, NO other air sanitization system in North America has been tested on live SARS-CoV-2 (COVID-19) aerosols and clinically proven to eliminate 100% of airborne SARS-CoV-2 (COVID-19) on a SINGLE pass.”
The ILLUVIA® decontaminates up to 2,500 square feet while the GermZone cleans rooms or spaces up to 600 square feet. Although the ILLUVIA® contains an internal Merv rated HEPA filter, these products are designed to sterilize and sanitize the air as it passes through the machine.
The Patented UVC Photolytic Chamber is the key technology that differentiates the Aerobiotix products from all other products on the market. The ability to slow the airflow down as it passes through the high-intensity UVC Light while ensuring zero Ozone emissions are essential requirements for any UVC light source to be safe and effective in eliminating bacteria and viruses including (COVID-19).
Prior to the onset of the pandemic, these machines were originally designed for use in hospital operating rooms, diagnostic, treatment and transition areas, and for use during aerosol-generating procedures that take place in intensive care units.
“Air quality management and getting all businesses back up and running safely with sustainable long-term confidence is our goal,” says Graham Brown, Director, Aerobiovac Canada.
“We can now make this technology and these powerful medical-grade systems more readily available to all Canadians to assist in the prevention of the spread of COVID-19 while providing effective air quality and protection post-pandemic.”
Brown would like to see the ILLUVIA® and GermZone used strategically to ensure the highest level of air quality in any indoor facility where the safety of the staff and the general public is of paramount concern. This includes COVID testing centres, long-term care facilities, retirement homes, schools, laboratory and medical offices, airports, condos, government offices, jails, places of worship, transit stations, grocery and retail stores.
Aerobiovac has submitted a proposal to the provincial government through their Ontario Together portal to offer priority access to the machines to assist our government in their fight against the coronavirus. Both the systems are made of the highest quality materials and manufactured in the US. The GermZone retails for $2900 and the much larger hospital-grade ILLUVIA® retails for $26,000 per unit.
Long-term benefits of using the ILLUVIA® and GermZone
- Provides a safe environment for employees, tenants, families and service providers.
- Ideal for high-traffic common areas like lobbies, vestibules, offices, and condo/apartment units.
- Will provide continued air quality and management and protection post-pandemic.
- Permanently supporting the reduction of infection (continually removes viruses, including the common flu).